Content
Search
Navigation
Sitemap
About us
Pipeline & science
Overview
Obesity
Acute Ischemic Stroke (AIS)
Hypertension
Our expertise
Overview
Our strategic partners
Global opportunities
Join us
Press releases
Contact
简体中文
Search
简体中文
Navigation
Press releases
28 Oct 2024
CORXEL and LENZ Therapeutics Announce Positive Topline Data from China Phase 3 Presbyopia Trial of LNZ100
Read article
18 Oct 2024
CORXEL Announces NMPA Acceptance of New Drug Application for Aficamten
Read article
06 Sep 2024
JIXING Announces Positive Results from Phase 3 JX02002 Clinical Trial of Etripamil Nasal Spray in Patients with Paroxysmal Supraventricular Tachycardia
Read article
02 Sep 2024
Cytokinetics Presents New Data Related to the Safety and Long-Term Use of Aficamten at the European Society of Cardiology Congress 2024
Read article
19 Aug 2024
JIXING Announces the Successful Completion of Patient Enrollment in Phase 3 Clinical Study of LNZ100 for the Treatment of Presbyopia in China
Read article
13 Aug 2024
LENZ Therapeutics Announces Submission of New Drug Application to U.S. Food and Drug Administration for LNZ100 for the Treatment of Presbyopia
Read article
Load more
